Genetic matters of CYP2D6 in breast cancer: copy number variations and nucleotide polymorphisms

被引：0
|
作者：
Ke-Da Yu
Zhi-Ming Shao
机构：
[1] Ke-Da Yu and Zhi-Ming Shao are at the Breast Cancer Institute,
[2] Cancer Hospital,undefined
[3] Shanghai Medical College,undefined
[4] Fudan University,undefined
来源：
Nature Reviews Cancer | 2009年 / 9卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：842 / 843
页数：1
相关论文
共 50 条
  • [41] Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy
    Damodaran, Solai Elango
    Pradhan, Suresh Chandra
    Umamaheswaran, Gurusamy
    Kadambari, Dharanipragada
    Reddy, K. Sathyanarayana
    Adithan, Chandrasekaran
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (01) : 75 - 81
  • [42] Genetic polymorphisms of CYP2D6 increase the risk for recurrence of breast cancer in patients receiving tamoxifen as an adjuvant therapy
    Solai Elango Damodaran
    Suresh Chandra Pradhan
    Gurusamy Umamaheswaran
    Dharanipragada Kadambari
    K. Sathyanarayana Reddy
    Chandrasekaran Adithan
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 75 - 81
  • [43] Pharmacogenetics of anesthetic and analgesic agents: CYP2D6 genetic variations
    Stamer, UM
    Stuber, F
    ANESTHESIOLOGY, 2005, 103 (05) : 1099 - 1099
  • [44] Genetic variations of human CYP2D6 in the Chinese Han population
    Qian, Jian-Chang
    Xu, Xin-Min
    Hu, Guo-Xin
    Dai, Da-Peng
    Xu, Ren-Ai
    Hu, Li-Ming
    Li, Fang-Hong
    Zhang, Xiu-Hua
    Yang, Jie-Fu
    Cai, Jian-Ping
    PHARMACOGENOMICS, 2013, 14 (14) : 1731 - 1743
  • [45] CYP2D6 polymorphisms influence the efficacy of adjuvant tamoxifen in Thai breast cancer patients
    Sirachainan, Ekaphop
    Jaruhathai, Sureerat
    Trachu, Narumol
    Panvichian, Ravat
    Sirisinha, Thitiya
    Ativitavas, Touch
    Ratanatharathorn, Vorachai
    Chamnanphon, Montri
    Sukasem, Chonlaphat
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2012, 5 : 149 - 153
  • [46] CYP2D6 polymorphisms in patients with porphyrias
    Lavandera, Jimena V.
    Parera, Victoria E.
    Batlle, Alcira
    Buzaleh, Ana Maria
    MOLECULAR MEDICINE, 2006, 12 (9-10) : 259 - 263
  • [47] CYP2D6 Polymorphisms in Patients with Porphyrias
    Jimena V. Lavandera
    Victoria E. Parera
    Alcira Batlle
    Ana María Buzaleh
    Molecular Medicine, 2006, 12 : 259 - 263
  • [48] CYP2D6 polymorphisms and tamoxifen: therapeutic perspectives in the management of hormonodependent breast cancer patients
    Barriere, J.
    Formento, J. -L.
    Milano, G.
    Ferrero, J. -M.
    BULLETIN DU CANCER, 2010, 97 (03) : 311 - 320
  • [49] Integrated CYP2D6 interrogation for multiethnic copy number and tandem allele detection
    Qiao, Wanqiong
    Martis, Suparna
    Mendiratta, Geetu
    Shi, Lisong
    Botton, Mariana R.
    Yang, Yao
    Gaedigk, Andrea
    Vijzelaar, Raymon
    Edelmann, Lisa
    Kornreich, Ruth
    Desnick, Robert J.
    Scott, Stuart A.
    PHARMACOGENOMICS, 2019, 20 (01) : 9 - 20
  • [50] CYP2D6 Allele-Specific Copy Number Determination by Digital PCR
    Wang, Wendy
    Boone, Erin
    Lin, Lancy
    Stevens, Junko
    Gaedigk, Andrea
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 15 - 16
12345